作为一颗核蛋白质的等离子素:调节小RNA载荷调节纤维解和炎症
Danielle L Michell1, Clark Massick1, Kaustubh S Koya1
1Vanderbilt Univ. Medical Center, Nashville, Tennessee, United States.
Blood
|June 25, 2025
概括
血原 (Plg) 携带小RNAs (sRNAs),影响其凝固和炎症功能. 删除sRNA载荷可以增强plgg.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 无细胞RNA (cf-RNA) 是细胞通信和血液静止的关键.
- 血原 (Plg) 是血的前体,对凝块分解至关重要.
研究的目的:
- 研究Plasminogen作为细胞外小型非编码RNAs (sRNAs) 的载体的作用.
- 确定Plg-sRNA相互作用对Plg纤维解和免疫性活动的功能影响.
主要方法:
- 氨酸 afinity 染色法用于净化 Plg.
- 在体外结合测试以评估Plg-sRNA相互作用.
- RNase消化以从Plg.中去除sRNA载荷.
- 巨细胞检测测量细胞因子的表达.
主要成果:
- 纯化Plg携带宿主和微生物sRNA (25-60核酸).
- Plg-sRNA复合体不同于HDL,并受到高胆固醇血症的影响.
- 从Plg中去除sRNA增加了等离子体活性,加速了凝块溶解,并减少了炎症.
结论:
- 细胞外的sRNAs调节了Plasminogen的纤维分析和免疫功能.
- Plg-sRNA相互作用代表了cf-RNA生物学与凝血之间的新联系.
- 向Plg-sRNA相互作用可能为血栓性和炎症性疾病提供新的治疗策略.
更多相关视频
相关概念视频
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Cytoskeletal Linker Proteins - Plakins
2.4K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.4K
Ribozymes
12.5K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
12.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
924
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
924
Translational Regulation
110
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
110
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K


